Esophageal / Gastric

Gastrointestinal

  • ECOG EA2142– A Randomized Phase II Study of Cisplatin and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropancreatic Neuorendocrine Carcinomas